Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

HHS Secretary Robert F. Kennedy Jr. was on The Tucker Carlson Show last week. It got me to thinking: What's next in RFK Jr.'s ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc.

A growing number of physicians shift focus to consulting and digital health roles for better work-life balance and financial ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

Objective Diverticular disease is a common complex disorder characterised by mucosal outpouchings of the colonic wall that manifests through complications such as diverticulitis, perforation and ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Traditional medical tests often require clinical samples to be sent off-site for analysis in a time-intensive and expensive ...

Scientists have gained an atomic-level view of plant cells, getting to know the metacaspase 9 enzyme in the process.

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how ...